Tip - Lilly, Bristol-Myers Squibb Restructure Erbitux® (cetuximab) Collaboration in North America

Eli Lilly and Company and Bristol-Myers Squibb Company today announced that the companies have agreed to transfer rights to Erbitux® in North America, including the U.S., Canada, and Puerto Rico, from Bristol-Myers Squibb to Lilly.